Page 41 - Sun Pharma News Today

(This story has not been edited by THE WEEK and is auto-generated from a PTI

Nischal Maheshwari, CEO of Centrum Broking, recommends green-oriented companies like Tata Power and NTPC in the metals and coal sectors. He suggests focusing on pharma companies like Sun Pharma and the hospital sector for investment opportunities. We are are strongly betting on goal-oriented companies. The power equipment companies have run much ahead of its course. We would recommend taking profits in BHEL kind of companies.

Among Sensex shares, Bajaj Finserve, ICICI Bank, Bharti Airtel, Bajaj Finance, Sun Pharma, Maruti Suzuki, ITC, and Nestle were the lead gainers. On the other hand, L&T Wipro, IndusInd Bank and TCS and Tata Motors were the lead losers.

Key stock indices closed in the green for the fifth straight day on Monday, gaining around 2.3 per cent

As many as 17 Sensex shares advanced while 13 closed in the red. After a firm start, the index hit a high of 72,881.93 in day trade.

Mumbai, Investors became richer by Rs 2.20 lakh crore on Monday and the market capitalisation of BSE-listed firms reached an all-time high of Rs 3.91 lakh

From the Sensex pack, Infosys, Wipro, Tata Motors, UltraTech Cement, and M&M opened with gains, while Power Grid, Sun Pharma, ITC, Axis Bank, and Reliance Industries opened with cuts.

Sandip Sabharwal discusses the pharma sector, IndiGo stock, PSU banks, hospital stocks, consumer sector, and the performance of ABFRL and Trent. Sabharwal says Aurobindo Pharma has some active accounting and the injectable facility issue may drag on some more time. Hindalco has been on a tear ex of this sell-off which has happened now, despite the fact that the entire aluminium, copper and the metal basket has gone nowhere.

N Jayakumar highlights the need to view the market differently due to the influx of younger, retail, aggressive investors. He suggests finding comfort in private sector banks, pharma stocks, OMCs, and power sectors. The market should shed historical baggage and focus on future potential. He said: "You need to learn from the past but you cannot ignore the present and therein lies the truth."

The recent successes of leading pharmaceutical products show that drug companies have been plain lucky to hit the jackpot. While long-term strategies continue to be important, drug makers have often struck gold with pipeline compounds that they had once simply dumped.